• Astrology
  • Lifestyle
  • Festivals
  • Filmibeat
  • Movie Trailers
  • APKs
  • Viral
  • Lyrics
  • Gaming
  • Pictures
  • More
    • GOVT Jobs
    • Adobe Xd
    • Sports
    • Big Boss 14
    • Status
    • Figma UI
    • Celebrity Interviews
    • Shayaris

Subscribe to Updates

Get the latest creative news from FooBar about art, design and business.

What's Hot

Super Singer 8 Vote: Kabhini Mithra and Jacquline in danger zone, who will get eliminated?

March 1, 2021

Riti Riwaj Taala Chaabi Ullu Web Series (2021) Full Episode: Watch Online

March 1, 2021

Be sure to log in to see EVERYTHING! : theCHIVE

March 1, 2021
Facebook Twitter Instagram
Monday, March 1
Trending
  • Super Singer 8 Vote: Kabhini Mithra and Jacquline in danger zone, who will get eliminated?
  • Riti Riwaj Taala Chaabi Ullu Web Series (2021) Full Episode: Watch Online
  • Be sure to log in to see EVERYTHING! : theCHIVE
  • Happy Confession Day 2021 Wishes Quotes Sms Messages Memes Whatsapp Status Dp Images
  • Boxing Gym Story MOD APK 1.1.4 (Unlimited Money) Download
  • IBPS Office Assistant Main Exam Result 2021 (CRP RRB IX) declared at ibps.in
  • Experts urge independent probe into Navalny’s poisoning
  • Sephora teams up with Coach for a quirky makeup collection
Facebook Twitter Instagram
Socially Keeda Socially Keeda
  • Astrology
  • Lifestyle
  • Festivals
  • Filmibeat
  • Movie Trailers
  • APKs
  • Viral
  • Lyrics
  • Gaming
  • Pictures
  • More
    • GOVT Jobs
    • Adobe Xd
    • Sports
    • Big Boss 14
    • Status
    • Figma UI
    • Celebrity Interviews
    • Shayaris
Socially Keeda Socially Keeda
Home » Coronavirus pandemic: India to begin production of Remdesivir to fight Covid-19
News

Coronavirus pandemic: India to begin production of Remdesivir to fight Covid-19

Socially KeedaBy Socially KeedaJune 14, 2020No Comments3 Mins Read
Facebook Twitter Pinterest LinkedIn Tumblr Email
Share
Facebook Twitter LinkedIn Pinterest Email

India is soon going to have its domestic production of anti-viral Remdesivir drug, which would have safety, efficacy and stability for “restricted emergency use” on COVID-19 patients. Recently, in the wake of the COVID-19 pandemic, the Drug Controller General of India (DCGI) has given the approval to Remdesivir for “restricted emergency use” on severely ill hospitalised coronavirus patients.

For this, the country’s top drug regulator is evaluating the application submitted by four domestic pharma giants who want to seek the approval to manufacture and sell Remdesivir in India.

“Their applications are being thoroughly studied and examined day and night. It had certain shortcomings for which the respective pharma companies are furnishing their report. The testing of the drug’s molecular compound will be done at our government laboratory. When it fulfills the safety parameters at the dose, India would soon have the benefit of its domestic product (Remdesivir) which have efficacy, stability and safety for ‘restricted emergency use’ on COVID-19 patients,” a senior government official told ANI.

“Remdesivir is a drug that is still under trial. Hence, looking at the COVID-19 situation in the country, it has been permitted for ‘restricted emergency use’ on COVID-19 patients. Doctors have to get the consent-form duly filled by the patient in a prescribed manner before using it,” he stated, adding that it is the first drug in India which has such strong control.

“The drug will be administered in the form of infection in five doses. On the first day, a patient will be given two doses followed by one dose for the next four days under the strict monitoring of doctors. The drug has to be given only to those severe COVID-19 patients with oxygen saturation level below 94 and respiratory rate more than 24,” the senior government official further said.

He informed that in other countries, patients are being administrated with 10 doses of Remdesivir.

Besides this, companies have to follow up each and every patient’s case with regard to the safety and efficacy of the drug to whom it is being administered.

“Pharma companies have been directed to conduct Active-Post Marketing Surveillance of each case and prepare a report on the benefit or recovery of a patient and provide the data report to us,” the official said, adding that these pharma companies have to submit a report to the government and also of a clinical trial being conducted anywhere in the world.

Remdesivir, an investigational antiviral therapy developed by Gilead, received Emergency Use Authorisation (EUA) by the US Food and Drug Administration (USFDA) to treat COVID-19. However, multiple additional clinical trials are ongoing to generate more data on the safety and efficacy of the drug as a treatment for the virus.

In the recent past, Gilead had signed non-exclusive voluntary licensing agreements with four generic pharma firms — Cipla, Jubilant Life Sciences, Hetero and Mylan to manufacture and distribute Remdesivir, a potential antiviral therapy for COVID-19.

According to Gilead, under the licensing agreements, the companies have a right to receive a technology transfer of the Gilead manufacturing process for Remdesivir to enable them to scale up production more quickly.

(This story has been published from a wire agency feed without modifications to the text. Only the headline has been changed.)

Follow more stories on Facebook and Twitter





Source

Related posts:

  1. Kepa Arrizabalaga to make first Chelsea begin since October
  2. Tottenham Hotspur 4-0 Ludogorets: Jose Mourinho praises Dele Alli
  3. Queens Park Rangers 3-2 Rotherham United: R’s report first win in three
  4. Arsenal 1-2 Wolves: Arteta ‘not fearful’ about his future regardless of loss
ageusia anosmia brain damage china coronavirus coronavirus india coronavirus india updates coronavirus lockdown coronavirus outbreak coronavirus pandemic Covid covid 19 Covid lockdown COVID19 fight global pandemic headache impairment of consciousness India Jaipur news latest news jaipur lock down lockdown outbreak pandemic production quarantine remdesivir seizure self isolation self quarantine social distancing socially keeda news stroke World Health Organisation Wuhan
Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
Socially Keeda
  • Website
  • Pinterest
  • Instagram
  • Tumblr
  • LinkedIn

Socially Keeda, the pioneer of news sources in India operates under the philosophy of keeping its readers informed. SociallyKeeda.com tells the story of India and it offers fresh, compelling content that’s useful and informative for its readers.

Related Posts

London, Ont., restaurant, bar, BMO Centre optimistic to move to orange zone – London

March 1, 2021

Police Arrested Three Youtubers Uploading Obscene Prank Video, Molesting Girls

March 1, 2021

Ontario surpasses 300K total COVID-19 cases as 1,062 new infections reported

February 28, 2021

Leave A Reply Cancel Reply

Editors Picks

Oculus Quest X Headset: Discover a Shining New Star

January 5, 2021

Fujifilm’s 102-Megapixel Camera is the Size of a Typical DSLR

January 5, 2021

Stars Rally to Beat Predators in Winter Basic at Cotton Bowl

December 22, 2020

Patrick Kane Will get 1,000th Level in Blackhawks Win

December 22, 2020
Trending
  • Suicide Squad (2016) Dual... posted on January 4, 2021
  • Drishyam 2 Download Full... posted on February 27, 2021
  • Charmsukh Jane Anjane Mei... posted on February 9, 2021
  • Palang Tod Bekaboo Dil posted on February 25, 2021
  • G Zombie OTT release date... posted on February 26, 2021
Singapore
Singapore

Sephora teams up with Coach for a quirky makeup collection

By Socially Keeda
Singapore

Singapore’s Foreign Minister calls on Myanmar’s military to stop using lethal force against civilians

By Socially Keeda
Singapore

[#SupportLocal] – Asian-inspired ceramic tableware from Table Matters to up your home dining foodstagram Game

By Socially Keeda
About Us

Socially Keeda, the pioneer of news sources in India operates under the philosophy of keeping its readers informed. SociallyKeeda.com tells the story of India and it offers fresh, compelling content that’s useful and informative for its readers.

Our Picks

It’s getting harder for Cabinet picks to get confirmed, data analysis shows

February 25, 2021

Hyundai’s Value Surges Amid Reports of Apple Electric Car Deal

January 4, 2021

Jason Holder Picks Six Wickets, Hosts All Out for 204

July 9, 2020
New Comments
  • sampada Deshmukh on Top 63 Google AdWords Interview Questions & Answers: Ultimate Guide 2021
  • Alomgir on Palang Tod Bekaboo Dil
  • GoalRealEstate.com on Fintech Investment App Figma Template
  • Socially Keeda on 101+ Best Preschool bios for Social media
Socially Keeda
Facebook Twitter Instagram Pinterest
  • About Us
  • DMCA
  • Disclaimer
  • Terms and Conditions
  • Privacy Policy
  • Submit Guest Post
  • Contact Us
© 2021 Copyright © SociallyKeeda.com All Rights Reserved.

Type above and press Enter to search. Press Esc to cancel.